PEPTIDES (peptides containing -lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D 519/02; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N 15/00)
| Patent # | Title | Filing Date | Issue Date | Patent Owner |
|---|---|---|---|---|
| 8,697,045 | Pegylated interleukin-10 | Aug 26, 11 | Apr 15, 14 | MERCK SHARP & DOHME CORPORATION |
| 8,697,047 | Stable immunogenic product comprising antigenic heterocomplexes | May 31, 11 | Apr 15, 14 | NEOVACS |
| 8,697,063 | Polypeptides having phytase activity and polynucleotides encoding same | Dec 16, 11 | Apr 15, 14 | NOVOZYMES A/S |
| 8,697,083 | for use in the treatment of allergies | Apr 11, 07 | Apr 15, 14 | BIAL INDUSTRIAL FARMACEUTICA, S.A. |
| 8,697,098 | Polymer conjugated protein micelles | Feb 24, 12 | Apr 15, 14 | SOUTH DAKOTA STATE UNIVERSITY |
| 8,697,111 | Osteochondral implant comprising osseous phase and chondral phase | May 12, 10 | Apr 15, 14 | COVIDIEN LP |
| 8,697,372 | Method for determining the binding of a given compound to a membrane receptor | Aug 12, 10 | Apr 15, 14 | CIS BIO INTERNATIONAL; CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE; |
| 8,697,376 | Synthetic protease substrates, assay methods using such substrates and kits for practicing the assay | Feb 03, 11 | Apr 15, 14 | LIFESENSORS INC. |
| 8,697,407 | Compositions and methods for inhibiting MMSET | Feb 11, 11 | Apr 15, 14 | THE REGENTS OF THE UNIVERSITY OF MICHIGAN |
| 8,697,412 | Polypeptides having glucoamylase activity and polynucleotides encoding same | Nov 28, 12 | Apr 15, 14 | NOVOZYMES A/S |
| 8,697,631 | TMEM22 peptides and vaccines including the same | Dec 13, 10 | Apr 15, 14 | ONCOTHERAPY SCIENCE INC. |
| 8,697,632 | Amide based insulin prodrugs | Dec 18, 09 | Apr 15, 14 | INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION |
| 8,697,645 | Second generation low oxygen affinity pegylated hemoglobins as oxygen-carrying plasma expanders | Mar 12, 08 | Apr 15, 14 | ALBERT EINSTEIN COLLEGE OF MEDICINE OF YESHIVA UNIVERSITY |
| 8,697,648 | Protein agent for diabetes treatment and β cell imaging | Oct 20, 10 | Apr 15, 14 | GEORGIA STATE UNIVERSITY RESEARCH FOUNDATION, INC. |
| 8,697,649 | Polypeptides, nucleic acid molecule encoding polypeptides, and uses of polypeptides | Jul 25, 12 | Apr 15, 14 | CHINA MEDICAL UNIVERSITY |
| 8,697,650 | HSA-related compositions and methods of use | Feb 15, 11 | Apr 15, 14 | MEDIMMUNE LLC |
| 8,697,655 | Method of selecting polypeptide sequence, and metal oxide or silicon-containing compound binding peptide and use thereof | Sep 10, 12 | Apr 15, 14 | RIKEN |
| 8,697,656 | Compounds, in particular peptides, compositions comprising them and cosmetic and dermo-pharmaceutical uses | Jan 15, 10 | Apr 15, 14 | SEDERMA |
| 8,697,836 | Composition and method for inducing and enhancing a telomerase reverse transcriptase-reactive cytotoxic T lymphocyte response | Apr 25, 08 | Apr 15, 14 | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA |
| 8,697,837 | Substrate for Rpn 11 enzymatic activity | Jul 20, 09 | Apr 15, 14 | ONYX THERAPEUTICS, INC. |
| Publication # | Title | Filing Date | Pub Date | Patent Owner |
|---|---|---|---|---|
| 2014/0105,821 | ANTIBODY THAT STOPS OR SLOWS TUMOUR GROWTH (VARIANTS) | Mar 30, 11 | Apr 17, 14 | Not available |
| 2014/0105,823 | MOLECULES SPECIFICALLY BINDING PANCREATIC BETA CELLS BIOMARKERS | Jun 22, 12 | Apr 17, 14 | UNIVERSITÉ DE MONS; EUROGENTEC SA; UNIVERSITÉ LIBRE DE BRUXELLES; |
| 2014/0105,854 | VACCINE FOR TREATMENT AND PREVENTION OF HERPES SIMPLEX VIRUS INFECTION | Aug 12, 13 | Apr 17, 14 | AGENUS INC. |
| 2014/0105,855 | STRUCTURAL BASED DESIGN OF IL-17 DOMINANT NEGATIVE MUTANTS | Apr 06, 12 | Apr 17, 14 | Not available |
| 2014/0105,856 | System and Method for Collagen Isolation | Jun 22, 12 | Apr 17, 14 | Not available |
| 2014/0105,859 | MODULATORS OF PHARMACOKINETIC PROPERTIES OF THERAPEUTICS | Dec 20, 13 | Apr 17, 14 | GILEAD SCIENCES INC. |
| 2014/0105,860 | ENGINEERED ANTIBODY-TNFSF MEMBER LIGAND FUSION MOLECULES | Jun 06, 12 | Apr 17, 14 | IMMUNGENE INC. |
| 2014/0105,888 | NOVEL MODULATORS AND METHODS OF USE | Feb 17, 12 | Apr 17, 14 | STEM CENTRX, INC. |
| 2014/0105,889 | METHOD FOR ALTERING PLASMA RETENTION AND IMMUNOGENICITY OF ANTIGEN-BINDING MOLECULE | Mar 30, 12 | Apr 17, 14 | CHUGAI SEIYAKU KABUSHIKI KAISHA |
| 2014/0105,890 | HUMANIZED ANTIBODIES SPECIFIC TO THE PROTOFIBRILLAR FORM OF THE BETA-AMYLOID PEPTIDE | Oct 01, 13 | Apr 17, 14 | SANOFI - AVENTIS |
| 2014/0105,894 | HUMANIZED ANTI-IL-18 ANTIBODIES | Dec 19, 13 | Apr 17, 14 | GLAXO GROUP LIMITED |
| 2014/0105,896 | FIBRONECTIN BASED SCAFFOLD DOMAIN PROTEINS THAT BIND TO MYOSTATIN | Sep 12, 13 | Apr 17, 14 | BRISTOL MYERS SQUIBB COMPANY |
| 2014/0105,897 | Novel Anti-IL13 Antibodies and Uses Thereof | Aug 20, 13 | Apr 17, 14 | GENENTECH, INC. |
| 2014/0105,899 | ANTIBODIES RECOGNIZING A CARBOHYDRATE CONTAINING EPITOPE ON CD-43 AND CEA EXPRESSED ON CANCER CELLS AND METHODS USING SAME | Sep 24, 13 | Apr 17, 14 | BIOALLIANCE C.V. |
| 2014/0105,900 | METHODS AND COMPOSITIONS RELATING TO ANTI-IL-21 RECEPTOR ANTIBODIES | Mar 14, 13 | Apr 17, 14 | AMGEN INC. |
| 2014/0105,901 | USE OF CBL AS BIOMARKER FOR IDENTIFYING SUBJECT SUITABLE FOR TREATMENT WITH ANTI-C-MET ANTIBODY | Jul 23, 13 | Apr 17, 14 | Not available |
| 2014/0105,902 | USE OF LRIG1 AS A BIOMARKER FOR IDENTIFYING A SUBJECT FOR APPLICATION OF ANTI-C-MET ANTIBODIES | Jul 23, 13 | Apr 17, 14 | Not available |
| 2014/0105,903 | Modulators of Plexin B2 Activity | Mar 28, 12 | Apr 17, 14 | PRESIDENT AND FELLOWS OF HARVARD COLLEGE |
| 2014/0105,904 | ANTHRAX AND SMALL POX REPLIKINS AND METHODS OF USE | Sep 13, 13 | Apr 17, 14 | Not available |
| 2014/0105,905 | High Affinity Fully Human Monoclonal Antibodies To Interleukin-8 And Epitopes For Such Antibodies | Nov 20, 13 | Apr 17, 14 | AMGEN FREMONT INC. |
